Axon Enterprise, Inc. (NASDAQ:AXON) Shares Bought by Asset Management One Co. Ltd.

Asset Management One Co. Ltd. grew its position in Axon Enterprise, Inc. (NASDAQ:AXON) by 3.3% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 26,642 shares of the biotechnology company’s stock after purchasing an additional 846 shares during the period. Asset Management One Co. Ltd.’s holdings in Axon Enterprise were worth $10,646,000 as of its most recent SEC filing.

Other institutional investors have also modified their holdings of the company. Motley Fool Asset Management LLC lifted its position in Axon Enterprise by 238.7% during the first quarter. Motley Fool Asset Management LLC now owns 492,140 shares of the biotechnology company’s stock valued at $153,981,000 after buying an additional 346,838 shares in the last quarter. 1832 Asset Management L.P. acquired a new position in shares of Axon Enterprise during the 1st quarter valued at $81,630,000. International Assets Investment Management LLC purchased a new stake in Axon Enterprise during the 3rd quarter worth $871,860,000. Vanguard Group Inc. increased its holdings in Axon Enterprise by 2.7% in the 1st quarter. Vanguard Group Inc. now owns 8,143,306 shares of the biotechnology company’s stock valued at $2,547,878,000 after purchasing an additional 212,401 shares in the last quarter. Finally, Swedbank AB acquired a new stake in Axon Enterprise in the 1st quarter valued at $39,923,000. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on the company. Barclays upped their target price on Axon Enterprise from $381.00 to $387.00 and gave the stock an “overweight” rating in a research report on Wednesday, August 7th. JMP Securities lifted their price objective on shares of Axon Enterprise from $430.00 to $500.00 and gave the company a “market outperform” rating in a research note on Thursday, October 31st. Craig Hallum upped their target price on shares of Axon Enterprise from $370.00 to $376.00 and gave the company a “buy” rating in a research note on Wednesday, August 7th. The Goldman Sachs Group raised their price target on shares of Axon Enterprise from $385.00 to $441.00 and gave the company a “buy” rating in a report on Wednesday, October 23rd. Finally, Northland Securities boosted their price objective on shares of Axon Enterprise from $330.00 to $365.00 and gave the stock an “outperform” rating in a report on Thursday, August 8th. Two equities research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $392.85.

Axon Enterprise Stock Performance

AXON stock opened at $459.52 on Thursday. The firm has a market cap of $34.73 billion, a P/E ratio of 121.25, a P/E/G ratio of 10.99 and a beta of 0.94. The stock’s 50 day simple moving average is $405.32 and its 200 day simple moving average is $343.13. The company has a current ratio of 2.88, a quick ratio of 2.52 and a debt-to-equity ratio of 0.35. Axon Enterprise, Inc. has a 12-month low of $212.88 and a 12-month high of $462.64.

Axon Enterprise (NASDAQ:AXON) last posted its quarterly earnings results on Tuesday, August 6th. The biotechnology company reported $1.20 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.02 by $0.18. Axon Enterprise had a net margin of 16.06% and a return on equity of 9.34%. The company had revenue of $504.00 million for the quarter, compared to the consensus estimate of $478.35 million. During the same period last year, the firm posted $0.80 EPS. The company’s revenue for the quarter was up 34.5% on a year-over-year basis. As a group, equities research analysts predict that Axon Enterprise, Inc. will post 1.79 EPS for the current year.

Insiders Place Their Bets

In other news, Director Julie A. Cullivan sold 900 shares of the company’s stock in a transaction that occurred on Thursday, September 5th. The stock was sold at an average price of $353.53, for a total transaction of $318,177.00. Following the completion of the transaction, the director now directly owns 3,653 shares of the company’s stock, valued at approximately $1,291,445.09. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, Director Julie A. Cullivan sold 900 shares of the company’s stock in a transaction on Thursday, September 5th. The stock was sold at an average price of $353.53, for a total transaction of $318,177.00. Following the completion of the transaction, the director now directly owns 3,653 shares in the company, valued at $1,291,445.09. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Michael Garnreiter sold 1,000 shares of the firm’s stock in a transaction on Tuesday, October 15th. The shares were sold at an average price of $437.98, for a total value of $437,980.00. Following the completion of the sale, the director now owns 26,259 shares in the company, valued at $11,500,916.82. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 371,172 shares of company stock valued at $137,000,162 over the last quarter. Insiders own 5.70% of the company’s stock.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.